Earnings
Pfizer's Q2 Performance: A Shift from Covid to Core Products and Future Outlook
Pfizer's Q2 earnings beat estimates, signaling a pivot from Covid-related revenue to strong sales in core prod…
James McAllister • Aug 4
Analysis
Unusual Options Activity Signals Bullish Sentiment for Microsoft
A surge in long-dated call options for Microsoft hints at bullish investor sentiment amid a rising market.
Marcus Rivera • Aug 4
Earnings
Palantir's Earnings Surge: A Bullish Signal for Tech Traders
Palantir's 16% post-Q2 earnings surge signals strong commercial revenue and AI demand, suggesting positive mar…
Sarah Chen • Aug 4
Earnings
Pfizer's Revenue Guidance Boost: A Shift in Focus
Pfizer beats Q2 estimates, raises revenue guidance, but reduces Covid product revenue expectations.
James McAllister • Aug 4
IPO
Curium-Lantheus Merger: What It Means for the Biotech Sector and Investors
The $8 billion merger between Curium and Lantheus could reshape the radiopharmaceutical landscape, impacting i…
Marcus Rivera • Aug 3
Technology
Visa's Strategic $2.4 Billion Acquisition of BioCatch: A Game Changer in Fraud Prevention
Visa's acquisition of BioCatch for $2.4 billion significantly boosts its fraud prevention capabilities in the …
Sarah Chen • Aug 3
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
More Stories